Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
First-Line Immune Tx: An Option in V600K-Mutant Melanoma medpagetoday.com/oncology/skinc… #skincancer #dermatology #dermatologia
RT @EmilyBaumrinMD: VITAL trial with no difference in incident cancer with high dose Vit D. Only looked at primary prevention. Any evidence…
The news letter of the french vitiligo patients association
mailchi.mp/afvitiligo/la-…
#dermatology #dermatologia…
https://twitter.com/i/web/status/1084728279079313408
RT @LancetDigitalH: Podcast: Listen to Editor-in-Chief Rupa Sarkar & Senior Editor Christina Wayman discuss the aims and scope of our new j…
The #LancetDigitalHealth is a new #OpenAccess journal publishing innovative & practice-changing research & opinion…
https://twitter.com/i/web/status/1084699768817942529
RT @AdeAdamson: Understanding Perceived Barriers of Minority Medical Students Pursuing a Career in Dermatology bit.ly/2FioUIj Majo…
RT @skinpact: You still have 4 days left to cast your vote in the 2018 SKINPACT Awards – The North American edition! See you at https://t.c…
RT @likeabduljabbar: Hey do you know what is NOT associated with bullous pemphigoid? Insulin. It’s cheap. It’s safe. It works. And yet we l…
RT @FeedHcp: DPP-4 Inhibitors Linked With Bullous Pemphigoid,,hcpfeed.com/2019/01/10/dpp…,
RT @RoxanaDaneshjou: Hey #dermtwitter! Before all of your busy schedules fill up, shall we set up an informal tweetup at AAD? (A tweetup is…